We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1526
Northwest Natural Holdings
NWN
$2.06B
| $190M | ﹤0.01% |
4,783,042
+27,198
| +0.6% | +$1.13M |
2013 Q2
48 quarters
|
|
1527
Energizer
ENR
$1.49B
| $190M | ﹤0.01% |
9,404,277
-17,716
| -0.2% | -$426K |
2015 Q3
39 quarters
|
|
1528
First Commonwealth Financial
FCF
$2.06B
| $190M | ﹤0.01% |
11,681,021
+98,002
| +0.8% | +$1.51M |
2013 Q2
48 quarters
|
|
1529
Argan
AGX
$4.85B
| $189M | ﹤0.01% |
858,956
-67,212
| -7% | -$12.1M |
2013 Q2
48 quarters
|
|
1530
Materion
MTRN
$5.11B
| $189M | ﹤0.01% |
2,385,854
-91,517
| -4% | -$7.22M |
2013 Q2
48 quarters
|
|
1531
Agios Pharmaceuticals
AGIO
$1.87B
| $189M | ﹤0.01% |
5,682,019
+77,428
| +1% | +$2.35M |
2013 Q3
47 quarters
|
|
1532
DELISTED
Hanesbrands
HBI
| $188M | ﹤0.01% |
41,113,188
+71,571
| +0.2% | +$345K |
2013 Q2
48 quarters
|
|
1533
Algonquin Power & Utilities
AQN
$4.04B
| $187M | ﹤0.01% |
32,658,546
+943,145
| +3% | +$5.17M |
2016 Q4
34 quarters
|
|
1534
Kinetik
KNTK
$4.45B
| $187M | ﹤0.01% |
4,241,053
+306,440
| +8% | +$13.5M |
2018 Q4
26 quarters
|
|
1535
Nelnet
NNI
$4.56B
| $187M | ﹤0.01% |
1,541,222
+5,653
| +0.4% | +$631K |
2013 Q2
48 quarters
|
|
1536
Northwest Bancshares
NWBI
$2.19B
| $186M | ﹤0.01% |
14,592,715
+115,683
| +0.8% | +$1.4M |
2013 Q2
48 quarters
|
|
1537
Alignment Healthcare
ALHC
$1.72B
| $186M | ﹤0.01% |
13,303,815
+2,189,919
| +20% | +$35.3M |
2021 Q1
17 quarters
|
|
1538
Werner Enterprises
WERN
$1.97B
| $186M | ﹤0.01% |
6,804,172
-8,866
| -0.1% | -$242K |
2013 Q2
48 quarters
|
|
1539
Rapid7
RPD
$850M
| $186M | ﹤0.01% |
8,024,349
-108,164
| -1% | -$2.56M |
2015 Q3
39 quarters
|
|
1540
LegalZoom.com
LZ
$1.04B
| $185M | ﹤0.01% |
20,790,108
+614,327
| +3% | +$5.15M |
2021 Q2
16 quarters
|
|
1541
CONMED
CNMD
$1.4B
| $185M | ﹤0.01% |
3,547,989
+42,414
| +1% | +$2.33M |
2013 Q2
48 quarters
|
|
1542
Summit Therapeutics
SMMT
$11.7B
| $185M | ﹤0.01% |
8,673,672
-2,966,835
| -25% | -$67.7M |
2020 Q4
18 quarters
|
|
1543
Central Garden & Pet Co Class A
CENTA
$2.27B
| $185M | ﹤0.01% |
5,897,088
+21,549
| +0.4% | +$673K |
2013 Q2
48 quarters
|
|
1544
Quaker Houghton
KWR
$2.7B
| $184M | ﹤0.01% |
1,644,491
+8,786
| +0.5% | +$954K |
2013 Q2
48 quarters
|
|
1545
BioCryst Pharmaceuticals
BCRX
$1.99B
| $184M | ﹤0.01% |
20,544,248
-1,115,517
| -5% | -$10.4M |
2013 Q2
48 quarters
|
|
1546
Lindsay Corp
LNN
$1.09B
| $183M | ﹤0.01% |
1,269,850
+33,652
| +3% | +$4.49M |
2013 Q2
48 quarters
|
|
1547
Teladoc Health
TDOC
$1.03B
| $183M | ﹤0.01% |
21,019,218
+1,266,880
| +6% | +$9.18M |
2015 Q3
39 quarters
|
|
1548
Tower Semiconductor
TSEM
$22.1B
| $183M | ﹤0.01% |
4,206,271
+119,116
| +3% | +$4.57M |
2015 Q1
41 quarters
|
|
1549
Recursion Pharmaceuticals
RXRX
$1.86B
| $183M | ﹤0.01% |
36,071,178
+3,783,201
| +12% | +$18.6M |
2021 Q2
16 quarters
|
|
1550
MaxLinear
MXL
$6.47B
| $182M | ﹤0.01% |
12,814,567
+1,023,309
| +9% | +$11.8M |
2013 Q2
48 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.